New chemo cocktail before transplant may stop leukemia relapse
NCT ID NCT01885689
First seen Nov 16, 2025 · Last updated Apr 30, 2026 · Updated 25 times
Summary
This study tests whether giving two chemotherapy drugs (clofarabine and melphalan) before a donor stem cell transplant can prevent leukemia from returning in patients whose cancer is in remission. The approach aims to kill any remaining cancer cells and help the donor cells take hold. The trial includes 72 adults with acute leukemia, myelodysplastic syndrome, or chronic myelomonocytic leukemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Conditions
Explore the condition pages connected to this study.